# CVS HEALTH CORPORATION (CVS) FY2024 Annual Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-12, accession number 0000064803-25-000007
- Page: https://plicit.ai/financials/cvs/fy2024-annual-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2024-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 253,215,000,000 US dollars
- **Current assets**: 68,645,000,000 US dollars
- **Non-current assets**: 184,570,000,000 US dollars
- **Liabilities**: 177,485,000,000 US dollars
- **Current liabilities**: 84,609,000,000 US dollars
- **Non-current liabilities**: 92,876,000,000 US dollars
- **Equity**: 75,730,000,000 US dollars
- **Noncontrolling interest**: 170,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 36,469,000,000 US dollars
- **Inventories**: 18,107,000,000 US dollars
- **Cash and cash equivalents**: 8,586,000,000 US dollars
- **Other current assets**: 3,076,000,000 US dollars
- **Investments**: 2,407,000,000 US dollars
- **Goodwill**: 91,272,000,000 US dollars
- **Long-term investments**: 28,934,000,000 US dollars
- **Intangible assets, net**: 27,323,000,000 US dollars
- **Operating lease right-of-use assets**: 15,944,000,000 US dollars
- **Property and equipment, net**: 12,993,000,000 US dollars
- **Other assets**: 4,793,000,000 US dollars
- **Separate accounts assets**: 3,311,000,000 US dollars
- **Pharmacy claims and discounts payable**: 24,166,000,000 US dollars
- **Accrued expenses and other current liabilities**: 20,810,000,000 US dollars
- **Accounts payable**: 15,892,000,000 US dollars
- **Health care costs payable**: 15,064,000,000 US dollars
- **Current portion of long-term debt**: 3,624,000,000 US dollars
- **Short-term debt**: 2,119,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,751,000,000 US dollars
- **Other insurance liabilities**: 1,183,000,000 US dollars
- **Long-term debt**: 60,527,000,000 US dollars
- **Long-term operating lease liabilities**: 14,899,000,000 US dollars
- **Other long-term liabilities**: 5,431,000,000 US dollars
- **Other long-term insurance liabilities**: 4,902,000,000 US dollars
- **Deferred income taxes**: 3,806,000,000 US dollars
- **Separate accounts liabilities**: 3,311,000,000 US dollars
- **Retained earnings**: 62,837,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and capital surplus**: 49,661,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 170,000,000 US dollars
- **Treasury stock, at cost: 518 and 480 shares at December 31, 2024 and 2023**: negative 36,818,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 120,000,000 US dollars
- **Gross equity (calculated)**: 112,668,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.